Works matching DE "CYTOCHROME P-450 CYP2C19"
Results: 286
The impact of CYP2C19 genotypes on steady-state plasma concentration of escitalopram in South Indian population with Major Depressive Disorder.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e123645
- By:
- Publication type:
- Article
Effects of the EM CYP2C19 type and MDR1 3435CC gene on Helicobacter pylori eradication rate in patients with duodenal ulcer by the four-drug regimen of rabeprazole, bismuth, tetracycline, and tinidazole.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e108090
- By:
- Publication type:
- Article
Pharmacogenomics in Psychiatry: An Asian Perspective.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Systematic review of economic evaluation studies in psychiatric pharmacogenomics.
- Published in:
- European Psychiatry, 2021, v. 64, p. S382, doi. 10.1192/j.eurpsy.2021.1024
- By:
- Publication type:
- Article
Characteristics and predictors of cardiovascular events related to CYP2C19 gene polymorphisms following acute coronary syndrome.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 19, p. 4347
- By:
- Publication type:
- Article
Toxic optic neuropathy due to voriconazole: possible potentiation by reduction of CYP2C19 activity.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 24, p. 7823
- By:
- Publication type:
- Article
The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 19, p. 6065
- By:
- Publication type:
- Article
Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago.
- Published in:
- Cardiology & Therapy, 2024, v. 13, n. 1, p. 191, doi. 10.1007/s40119-024-00348-7
- By:
- Publication type:
- Article
Computational pharmacogenotype extraction from clinical next-generation sequencing.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1199741
- By:
- Publication type:
- Article
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?
- Published in:
- Genes, 2024, v. 15, n. 5, p. 607, doi. 10.3390/genes15050607
- By:
- Publication type:
- Article
CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia.
- Published in:
- Genes, 2023, v. 14, n. 10, p. 1945, doi. 10.3390/genes14101945
- By:
- Publication type:
- Article
Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners.
- Published in:
- Genes, 2023, v. 14, n. 10, p. 1841, doi. 10.3390/genes14101841
- By:
- Publication type:
- Article
Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors.
- Published in:
- Genes, 2023, v. 14, n. 3, p. 578, doi. 10.3390/genes14030578
- By:
- Publication type:
- Article
The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics.
- Published in:
- Genes, 2021, v. 12, n. 11, p. 1758, doi. 10.3390/genes12111758
- By:
- Publication type:
- Article
Exploring the Kinh Vietnamese genomic database for the polymorphisms of the P450 genes towards precision public health.
- Published in:
- Annals of Human Biology, 2022, v. 49, n. 2, p. 152, doi. 10.1080/03014460.2022.2052961
- By:
- Publication type:
- Article
The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack.
- Published in:
- Expert Review of Clinical Pharmacology, 2022, v. 15, n. 7, p. 811, doi. 10.1080/17512433.2022.2108401
- By:
- Publication type:
- Article
Population pharmacokinetics of omeprazole in obese and normal-weight adults.
- Published in:
- Expert Review of Clinical Pharmacology, 2022, v. 15, n. 4, p. 461, doi. 10.1080/17512433.2022.2075343
- By:
- Publication type:
- Article
Perioperative platelet reactivity over time in patients undergoing vascular surgery: An observational pilot study.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304800
- By:
- Publication type:
- Article
Impact of CYP2C19 Gene Variants on Long-Term Treatment with Atorvastatin in Patients with Acute Coronary Syndromes.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5385, doi. 10.3390/ijms25105385
- By:
- Publication type:
- Article
A Conserved Allosteric Site on Drug-Metabolizing CYPs: A Systematic Computational Assessment.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 24, p. 13215, doi. 10.3390/ijms222413215
- By:
- Publication type:
- Article
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 6, p. 1397, doi. 10.1007/s10557-023-07534-0
- By:
- Publication type:
- Article
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y<sub>12</sub> Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 447, doi. 10.1007/s10557-022-07392-2
- By:
- Publication type:
- Article
Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1147, doi. 10.1007/s10557-021-07142-w
- By:
- Publication type:
- Article
Perkütan koroner gı̇rı̇şı̇m sonrası klopı̇dogrel dı̇rencı̇nı̇n CYP2C9 ve CYP2C19 genlerı̇nı̇n kopya sayısı varyasyonu ile ı̇lı̇şkı̇sı̇
- Published in:
- Mersin Üniversitesi sağlık Bilimleri Dergisi, 2024, v. 17, n. 2, p. 262, doi. 10.26559/mersinsbd.1392360
- By:
- Publication type:
- Article
The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine.
- Published in:
- Application of Clinical Genetics, 2024, v. 17, p. 95, doi. 10.2147/TACG.S463965
- By:
- Publication type:
- Article
Study on the effect of CYP2C19 genetic polymorphism and plasma concentration on clopidogrel resistance.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2021, v. 34, n. 5, p. 1685, doi. 10.36721/PJPS.2021.34.5.REG.1685-1691.1
- By:
- Publication type:
- Article
Effect of MDR1 C3435T and CYP2C19 genetic polymorphisms on the outcome of Helicobacter pylori eradication treatment in children with gastritis and peptic ulcer, Vietnam.
- Published in:
- BMC Pediatrics, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12887-024-04581-w
- By:
- Publication type:
- Article
Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
No rebound effect after a course of clopidogrel in patients with acute TIA or minor stroke.
- Published in:
- Neurological Research, 2022, v. 44, n. 11, p. 957, doi. 10.1080/01616412.2022.2075660
- By:
- Publication type:
- Article
The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2023, v. 28, p. 1, doi. 10.1177/10742484231210704
- By:
- Publication type:
- Article
Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484221143246
- By:
- Publication type:
- Article
Assessment of Risk Factors for Drug Resistance of Dual Anti Platelet Therapy After PCI.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221083674
- By:
- Publication type:
- Article
艾司西酞普兰血药浓度/ 剂量比的影响因素研究.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2022, v. 22, n. 6, p. 668, doi. 10.14009/j.issn.1672-2124.2022.06.008
- By:
- Publication type:
- Article
Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 12, p. 3245, doi. 10.3390/biomedicines11123245
- By:
- Publication type:
- Article
Effect of major CYP2C19 genetic polymorphisms on Helicobacter pylori eradication based on different treatment regimens.
- Published in:
- Biomedical Reports, 2022, v. 16, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Meta‐Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib Exposure.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 10, p. 1098, doi. 10.1002/cpdd.1465
- By:
- Publication type:
- Article
Evaluation of Drug–Drug Interaction Potential of Enarodustat (JTZ‐951) Using a Cytochrome P450 Probe Cocktail.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 7, p. 667, doi. 10.1002/cpdd.1263
- By:
- Publication type:
- Article
Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 553, doi. 10.1002/cpdd.1255
- By:
- Publication type:
- Article
Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1469, doi. 10.1002/cpdd.966
- By:
- Publication type:
- Article
Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 1007, doi. 10.1002/cpdd.956
- By:
- Publication type:
- Article
Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1216433
- By:
- Publication type:
- Article
The impact of CYP2C19 genotype on phenoconversion by concomitant medication.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1201906
- By:
- Publication type:
- Article
From gene to dose: Long-read sequencing and *-allele tools to refine phenotype predictions of CYP2C19.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1076574
- By:
- Publication type:
- Article
The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1080117
- By:
- Publication type:
- Article
Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2022.931405
- By:
- Publication type:
- Article
Comprehensive in vitro and in silico assessments of metabolic capabilities of 24 genomic variants of CYP2C19 using two different substrates.
- Published in:
- Frontiers in Pharmacology, 2023, v. 13, p. 1, doi. 10.3389/fphar.2023.1055991
- By:
- Publication type:
- Article
Machine learning advances the integration of covariates in population pharmacokinetic models: Valproic acid as an example.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.994665
- By:
- Publication type:
- Article
Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.889473
- By:
- Publication type:
- Article
Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.938419
- By:
- Publication type:
- Article
Population pharmacokinetics model for escitalopram in Chinese psychiatric patients: effect of CYP2C19 and age.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.964758
- By:
- Publication type:
- Article